期刊
INTERNAL MEDICINE JOURNAL
卷 35, 期 12, 页码 726-728出版社
BLACKWELL PUBLISHING
DOI: 10.1111/j.1445-5994.2005.00949.x
关键词
hypocalcaemia; bisphosphonate; pamidronate; zoledronate; multiple myeloma
We report three cases of severe hypocalcaemia associated with i.v. bisphosphonate treatment in patients with multiple myeloma. All patients had symptomatic hypocalcaemia, including a tonic-clonic seizure and tachyarrhythmia in one case. Two cases were associated with the development of acute renal failure, whereas the third patient had pre-existing renal impairment. We recommend that bisphosphonates be used with caution in patients with myeloma and renal impairment, that vitamin D deficiency be corrected prior to treatment (to reduce the risk of hypocalcaemia) and that serum calcium and renal function be monitored during treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据